California State Teachers Retirement System (CalSTRS)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86.2M Sell
164,123
-1,973
-1% -$1.04M 0.1% 185
2025
Q1
$105M Sell
166,096
-1,793
-1% -$1.14M 0.13% 146
2024
Q4
$120M Sell
167,889
-5,256
-3% -$3.74M 0.14% 128
2024
Q3
$182M Sell
173,145
-582
-0.3% -$612K 0.21% 85
2024
Q2
$183M Buy
173,727
+678
+0.4% +$713K 0.22% 80
2024
Q1
$167M Buy
173,049
+1,648
+1% +$1.59M 0.21% 94
2023
Q4
$151M Buy
171,401
+661
+0.4% +$581K 0.21% 96
2023
Q3
$141M Sell
170,740
-5,820
-3% -$4.79M 0.22% 89
2023
Q2
$127M Sell
176,560
-3,159
-2% -$2.27M 0.18% 104
2023
Q1
$148M Sell
179,719
-1,830
-1% -$1.5M 0.22% 91
2022
Q4
$131M Buy
181,549
+1,679
+0.9% +$1.21M 0.21% 99
2022
Q3
$124M Sell
179,870
-250
-0.1% -$172K 0.21% 90
2022
Q2
$106M Buy
180,120
+2,863
+2% +$1.69M 0.17% 115
2022
Q1
$124M Sell
177,257
-8,530
-5% -$5.96M 0.16% 114
2021
Q4
$117M Buy
185,787
+8,546
+5% +$5.4M 0.14% 132
2021
Q3
$107M Buy
177,241
+975
+0.6% +$590K 0.14% 129
2021
Q2
$98.5M Sell
176,266
-9,837
-5% -$5.49M 0.12% 144
2021
Q1
$88.1M Buy
186,103
+1,091
+0.6% +$516K 0.12% 150
2020
Q4
$89.4M Buy
185,012
+4,431
+2% +$2.14M 0.13% 139
2020
Q3
$101M Buy
180,581
+5,411
+3% +$3.03M 0.16% 111
2020
Q2
$109M Buy
175,170
+29,452
+20% +$18.4M 0.19% 98
2020
Q1
$71.2M Sell
145,718
-509
-0.3% -$249K 0.15% 126
2019
Q4
$54.9M Buy
146,227
+10,572
+8% +$3.97M 0.09% 194
2019
Q3
$37.6M Buy
135,655
+976
+0.7% +$271K 0.07% 253
2019
Q2
$42.2M Buy
134,679
+2,251
+2% +$705K 0.08% 223
2019
Q1
$54.4M Buy
132,428
+2,327
+2% +$956K 0.11% 178
2018
Q4
$48.6M Buy
130,101
+2,647
+2% +$989K 0.11% 173
2018
Q3
$51.5M Buy
127,454
+6
+0% +$2.42K 0.1% 189
2018
Q2
$44M Buy
127,448
+1,346
+1% +$464K 0.09% 203
2018
Q1
$43.4M Sell
126,102
-4,303
-3% -$1.48M 0.09% 208
2017
Q4
$49M Sell
130,405
-768
-0.6% -$289K 0.1% 193
2017
Q3
$58.7M Sell
131,173
-13,349
-9% -$5.97M 0.13% 159
2017
Q2
$71M Sell
144,522
-9,948
-6% -$4.89M 0.15% 134
2017
Q1
$59.9M Sell
154,470
-7,200
-4% -$2.79M 0.12% 169
2016
Q4
$59.3M Sell
161,670
-4,200
-3% -$1.54M 0.12% 168
2016
Q3
$66.7M Buy
165,870
+1,400
+0.9% +$563K 0.14% 144
2016
Q2
$57.4M Sell
164,470
-2,240
-1% -$782K 0.12% 158
2016
Q1
$60.1M Buy
166,710
+21,324
+15% +$7.69M 0.13% 153
2015
Q4
$78.9M Buy
145,386
+2,315
+2% +$1.26M 0.19% 102
2015
Q3
$66.5M Sell
143,071
-200
-0.1% -$93K 0.17% 114
2015
Q2
$73.1M Sell
143,271
-1,261
-0.9% -$643K 0.18% 110
2015
Q1
$65.3M Sell
144,532
-2,500
-2% -$1.13M 0.15% 127
2014
Q4
$60.3M Buy
147,032
+1,422
+1% +$583K 0.14% 143
2014
Q3
$52.5M Sell
145,610
-743
-0.5% -$268K 0.13% 153
2014
Q2
$41.3M Buy
146,353
+670
+0.5% +$189K 0.1% 190
2014
Q1
$43.7M Buy
145,683
+700
+0.5% +$210K 0.12% 176
2013
Q4
$39.9M Buy
144,983
+1,000
+0.7% +$275K 0.11% 184
2013
Q3
$45M Buy
143,983
+4,418
+3% +$1.38M 0.13% 143
2013
Q2
$31.4M Buy
+139,565
New +$31.4M 0.1% 196